H.R. 747 · 119th Congress · International Affairs

Stop Chinese Fentanyl Act of 2025

Expands sanctions on Chinese entities and officials involved in fentanyl trafficking through 2029. AI-read

Passed House898 words Introduced Jan 28, 2025 · Latest action Sep 3, 2025

How far it has goneStage 4 of 6
  1. IntroducedJan 28, 2025 Done
  2. CommitteeReported Mar 21, 2025 Done
  3. House floorPassed 407–⁠4 · Sep 2, 2025 Done
  4. Senate floorIn Senate committee Current stage
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill subjects certain Chinese entities and government officials to potential sanctions related to opioid trafficking and requires the President to conduct certain preliminary analyses before regulating economic transactions in the event of a national emergency related to international drug trafficking.

Specifically, for the purposes of the Fentanyl Sanctions Act, the bill changes the definition of foreign opioid trafficker to specify that the term includes (1) Chinese entities involved in the production or sale of synthetic opioids or related pharmaceutical ingredients that fail to take steps to detect or prevent opioid trafficking; and (2) certain senior Chinese government officials that aid and abet opioid trafficking, including through intentional inaction. Under current law, the President must impose certain sanctions on individuals and entities identified as foreign opioid traffickers.

Further, the bill extends through 2029 an existing requirement that the President report to Congress annually on identified foreign opioid traffickers and any sanctions imposed on them. (This requirement expired in December 2024.)

The bill also requires the President to take additional steps in issuing regulations under the International Emergency Economic Powers Act (IEEPA) pursuant to a declared national emergency related to international drug trafficking. (IEEPA authorizes the President to regulate a variety of economic transactions following a declaration of national emergency.) Under the bill, the President must evaluate the costs and benefits of issuing economic regulations for the purpose of resolving the drug trafficking emergency and publish a discussion of such costs and benefits.

Congressional Research Service · summary of “Introduced in House” version · Jan 28, 2025

Votes

  1. House · On Motion to Suspend the Rules and Pass, as Amended Sep 2, 2025 · Roll call 220
    407–4Passed

Top row Yea · bottom row NayD left, R rightDemocratsRepublicans

Who lobbies on it

No lobbying filing on file names H.R. 747.

Organizations that named H.R. 747 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

16 actions · newest first
  1. Sep 3, 2025Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  2. Sep 2, 2025Motion to reconsider laid on the table Agreed to without objection.
  3. Sep 2, 2025On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
  4. Sep 2, 2025Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
Show all 16 actionsShow fewer
  1. Sep 2, 2025Considered as unfinished business. (consideration: CR H3741-3742)
  2. Sep 2, 2025At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  3. Sep 2, 2025DEBATE - The House proceeded with forty minutes of debate on H.R. 747.
  4. Sep 2, 2025Considered under suspension of the rules. (consideration: CR H3728-3731)
  5. Sep 2, 2025Mr. Baumgartner moved to suspend the rules and pass the bill, as amended.
  6. Apr 9, 2025Ordered to be Reported in the Nature of a Substitute by Voice Vote.
  7. Apr 9, 2025Committee Consideration and Mark-up Session Held
  8. Mar 21, 2025Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
  9. Mar 5, 2025Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
  10. Mar 5, 2025Committee Consideration and Mark-up Session Held
  11. Jan 28, 2025Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  12. Jan 28, 2025Introduced in House

What members said about it

  • Statement · Press release · Dec 19, 2025 · Tran D-CA

    Representatives Tran, Hurd, Dean Introduce Bipartisan Legislation to Combat Youth Substance Use

    Yesterday, U.S. Representative Derek Tran (D-CA-45), alongside Representatives Jeff Hurd (R-CO-03) and Madeleine Dean (D-PA-04), introduced bipartisan legislation to prevent youth substance use.

    “As online misinformation increasingly impacts young people, it is more important than ever to distribute reliable, factual information about the impacts of substance abuse. My bill would make it easier for children and teenagers to access preventative educational materials about drugs and other harmful substances that…”
  • Statement · Press release · Sep 5, 2025 · Moore R-AL

    Rep. Barry Moore supports Stop Chinese Fentanyl Act of 2025

    Representative Barry Moore (AL-01) announced his support for H.R. 747, the Stop Chinese Fentanyl Act of 2025.

    “Every day, American families are being torn apart by fentanyl. It is now the number one killer of young adults in our country, and we know much of it has been flowing here from China and through Biden's wide-open southern border.”
  • Statement · Press release · Sep 4, 2025 · Bresnahan R-PA

    House passes Bresnahan-cosponsored legislation to hold China accountable for fentanyl trafficking

    The legislation, cosponsored by Rep. Bresnahan, passed the House yesterday by a vote of 407-4.

    “The fentanyl crisis is the most urgent public health and public safety threat facing our nation today.”
  • Statement · Press release · Sep 3, 2025 · Bresnahan R-PA

    Anti fentanyl trafficking legislation co-sponsored by Bresnahan passes House

    U.S. Rep. Rob Bresnahan Jr. said on Wednesday that the fentanyl crisis is the most urgent public health and public safety threat facing our nation today.

    “Families in every community have been shattered by this poison, which often traces back to Chinese producers and the precursor chemicals they ship around the world.”
  • Statement · Press release · Sep 3, 2025 · Bresnahan R-PA

    House Passes Bresnahan-Cosponsored Legislation to Hold China Accountable for Fentanyl Trafficking

    Today, U.S. Representative Rob Bresnahan, Jr. (PA-08) released the following statement after yesterday’s passage of H.R. 747, the Stop Chinese Fentanyl Act of 2025.

    “The fentanyl crisis is the most urgent public health and public safety threat facing our nation today.”
  • Statement · Press release · Sep 3, 2025 · Escobar D-TX

    Congresswoman Escobar Votes to Hold Chinese Fentanyl Manufacturers Accountable

    Last night, Congresswoman Veronica Escobar voted in favor of H.R. 747, the Stop Chinese Fentanyl Act, to hold the Chinese Communist Party (CCP) and its affiliates accountable for manufacturing and distributing fentanyl.

    “Too many American families know the profound cost of the opioid epidemic, including in our community. That’s why I joined an overwhelming majority of my colleagues – Democrats and Republicans – to vote for this bill.”
  • Statement · Press release · Sep 2, 2025 · Harrigan R-NC

    Congressman Pat Harrigan Votes to Sanction Chinese Fentanyl Producers

    Today, Congressman Pat Harrigan (NC-10) voted to pass H.R. 747, the Stop Chinese Fentanyl Act of 2025, bipartisan legislation that sanctions Chinese producers of synthetic opioids and holds senior officials in Beijing accountable for…

    “Fentanyl is the leading killer of young Americans, and its trail runs straight back to Chinese labs and the officials who protect them.”